Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/FCF ratio high or low?
The Price/FCF ratio of 80.35 is 25% below its estimated 1-year average of 106.42, near the low end of its estimated 1-year range (80.35–138.32).
As of 2026-10-06T12:50:32.061Z.
Calculation as of: 2026-10-06T12:50:32.061Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b9d80053686f16721d19c62710da14dda18ff2c6e5fba2adc15c1c35f0ac96a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
80.35
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
20.93
median of 145 covered companies
CURRENT VS SECTOR MEDIAN
+283.90%
vs the sector median at left
Arcutis Biotherapeutics, Inc.
Market Cap
$3.15B
Price/FCF Ratio
80.35
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.16B
Price/FCF Ratio
N/A
TTM Avg
16.27
3Y Avg
21.05
5Y Avg
21.05
Market Cap
$3.09B
Price/FCF Ratio
N/A
TTM Avg
20.86
3Y Avg
20.86
5Y Avg
20.86
Market Cap
$2.87B
Price/FCF Ratio
36.29
TTM Avg
52.84
3Y Avg
87.29
5Y Avg
87.29
Market Cap
$3.44B
Price/FCF Ratio
19.75
TTM Avg
26.73
3Y Avg
53.68
5Y Avg
53.68
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.15B | 80.35 | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | 16.27 | 21.05 | 21.05 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 20.86 | 20.86 | 20.86 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 36.29 | 52.84 | 87.29 | 87.29 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 55.87 | 72.35 | 93.08 | 93.08 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 19.75 | 26.73 | 53.68 | 53.68 |
| Celcuity Inc. (CELC)vs › | $3.59B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 17.01 | 18.59 | 43.84 | 62.13 |
P/FCF Ratio
80.3
FCF Yield
1.24%
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-10-05 | 87.30 |
| 2026-10-02 | 87.33 |
| 2026-10-01 | 87.78 |
| 2026-09-30 | 91.74 |
| 2026-09-29 | 92.85 |
| 2026-09-28 | 94.87 |
| 2026-09-25 | 93.44 |
| 2026-09-24 | 91.19 |
| 2026-09-23 | 91.57 |
| 2026-09-22 | 96.43 |
| 2026-09-21 | 90.11 |
| 2026-09-18 | 88.10 |
| 2026-09-17 | 91.85 |
| 2026-09-16 | 90.74 |
| 2026-09-15 | 81.61 |
| 2026-09-14 | 84.24 |
| 2026-09-11 | 82.93 |
| 2026-09-10 | 81.15 |
| 2026-09-09 | 82.75 |
| 2026-09-08 | 84.66 |
| 2026-09-04 | 82.96 |
| 2026-09-03 | 82.13 |
| 2026-09-02 | 82.79 |
| 2026-09-01 | 82.44 |
| 2026-08-31 | 83.20 |
| 2026-08-28 | 82.54 |
| 2026-08-27 | 86.33 |
| 2026-08-26 | 87.26 |
| 2026-08-25 | 86.29 |
| 2026-08-24 | 86.01 |
| 2026-08-21 | 87.06 |
| 2026-08-20 | 87.99 |
| 2026-08-19 | 91.85 |
| 2026-08-18 | 92.12 |
| 2026-08-17 | 88.90 |
| 2026-08-14 | 90.91 |
| 2026-08-13 | 89.66 |
| 2026-08-12 | 91.22 |
| 2026-08-11 | 91.05 |
| 2026-08-10 | 89.97 |
| 2026-08-07 | 87.78 |
| 2026-08-06 | 91.74 |
| 2026-08-05 | 130.25 |
| 2026-08-04 | 125.11 |
| 2026-08-03 | 124.67 |
| 2026-07-31 | 129.10 |
| 2026-07-30 | 134.53 |
| 2026-07-29 | 133.90 |
| 2026-07-28 | 136.59 |
| 2026-07-27 | 133.81 |
| 2026-07-24 | 131.45 |
| 2026-07-23 | 131.35 |
| 2026-07-22 | 134.09 |
| 2026-07-21 | 135.82 |
| 2026-07-20 | 132.32 |
| 2026-07-17 | 136.93 |
| 2026-07-16 | 133.33 |
| 2026-07-15 | 133.52 |
| 2026-07-14 | 128.86 |
| 2026-07-13 | 130.35 |
| 2026-07-10 | 133.33 |
| 2026-07-09 | 138.32 |
| 2026-07-08 | 136.98 |
| 2026-07-07 | 132.99 |
| 2026-07-06 | 125.30 |
| 2026-07-02 | 124.05 |
| 2026-07-01 | 124.19 |
| 2026-06-30 | 126.02 |
| 2026-06-29 | 128.62 |
| 2026-06-26 | 129.77 |
| 2026-06-25 | 128.28 |
| 2026-06-24 | 131.55 |
| 2026-06-23 | 126.26 |
| 2026-06-22 | 128.13 |
| 2026-06-18 | 125.97 |
| 2026-06-17 | 126.02 |
| 2026-06-16 | 123.38 |
| 2026-06-15 | 122.94 |
| 2026-06-12 | 117.18 |
| 2026-06-11 | 118.19 |
| 2026-06-10 | 111.65 |
| 2026-06-09 | 109.53 |
| 2026-06-08 | 103.53 |
| 2026-06-05 | 102.04 |
| 2026-06-04 | 105.50 |
| 2026-06-03 | 102.61 |
| 2026-06-02 | 99.92 |
| 2026-06-01 | 103.19 |
| 2026-05-29 | 103.14 |
| 2026-05-28 | 103.05 |
| 2026-05-27 | 101.65 |
| 2026-05-26 | 101.46 |
| 2026-05-22 | 100.26 |
| 2026-05-21 | 100.98 |
| 2026-05-20 | 98.38 |
| 2026-05-19 | 93.72 |
| 2026-05-18 | 96.27 |
| 2026-05-15 | 102.47 |
| 2026-05-14 | 103.67 |
| 2026-05-13 | 104.25 |
| 2026-05-12 | 99.44 |
| 2026-05-11 | 102.08 |
| 2026-05-08 | 101.75 |
| 2026-05-07 | 99.30 |
